 <h1>Glucotrol XL Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>glipizide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about glipizide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Glucotrol XL.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to glipizide: oral tablet, oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, glipizide (the active ingredient contained in Glucotrol XL) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking glipizide:</p><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chills</li>
<li>cold sweats</li>
<li>coma</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>depression</li>
<li>difficulty with moving</li>
<li>dizziness</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>headache</li>
<li>increased hunger</li>
<li>joint pain</li>
<li>leg cramps</li>
<li>muscle aching or cramping</li>
<li>muscle pain or stiffness</li>
<li>nausea</li>
<li>nervousness</li>
<li>nightmares</li>
<li>pain in the joints</li>
<li>problems in urination or increase in the amount of urine</li>
<li>seizures</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>sweating</li>
<li>swollen joints</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>bloating</li>
<li>bloody or black, tarry stools</li>
<li>body aches or pain</li>
<li>burning, dry, or itching eyes</li>
<li>clay-colored stools</li>
<li>congestion</li>
<li>constipation</li>
<li>cough</li>
<li>dark urine</li>
<li>decreased vision or other changes in vision</li>
<li>diarrhea</li>
<li>difficult or labored breathing</li>
<li>difficult or painful urination</li>
<li>dryness or soreness of the throat</li>
<li>excessive tearing</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>feeling of warmth</li>
<li>fever</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>indigestion</li>
<li>itching</li>
<li>loss of appetite</li>
<li>pain in the eye</li>
<li>pounding in the ears</li>
<li>rash</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>runny nose</li>
<li>severe stomach pain</li>
<li>shortness of breath</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>trouble in swallowing</li>
<li>unpleasant breath odor</li>
<li>voice changes</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>wheezing</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>back or leg pains</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>chest pain</li>
<li>convulsions</li>
<li>decreased urine output</li>
<li>fluid-filled skin blisters</li>
<li>general body swelling</li>
<li>general feeling of tiredness or weakness</li>
<li>high fever</li>
<li>hostility</li>
<li>increased thirst</li>
<li>irritability</li>
<li>lethargy</li>
<li>light-colored stools</li>
<li>lower back or side pain</li>
<li>muscle twitching</li>
<li>nosebleeds</li>
<li>pinpoint red pots on the skin</li>
<li>rapid weight gain</li>
<li>sensitivity to the sun</li>
<li>skin thinness</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stupor</li>
<li>swelling of the face, ankles, or hands</li>
<li>unusual bleeding or bruising</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of glipizide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Indigestion</li>
<li>passing of gas</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>excess air or gas in the stomach or intestines</li>
<li>full feeling</li>
<li>pain</li>
<li>sleeplessness</li>
<li>sneezing</li>
<li>stuffy nose</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Decreased interest in sexual intercourse</li>
<li>dizziness or lightheadedness</li>
<li>excessive muscle tone</li>
<li>feeling of constant movement of self or surroundings</li>
<li>flushing or redness of the skin</li>
<li>headache, severe and throbbing</li>
<li>hives or welts</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>mood or mental changes</li>
<li>muscle stiffness</li>
<li>muscle tension or tightness</li>
<li>sensation of spinning</li>
<li>skin rash, encrusted, scaly, and oozing</li>
<li>sleepiness or unusual drowsiness</li>
<li>unusually warm skin</li>
<li>walking in unusual manner</li>
<li>weight loss</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Increased sensitivity of the skin to sunlight</li>
<li>severe sunburn</li>
</ul><p>
<!-- end oral tablet, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glipizide: compounding powder, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The more commonly reported side effects have included dizziness, diarrhea, nervousness, tremor, hypoglycemia, and flatulence.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Disulfiram-like reactions have been reported with sulfonylureas.  Clinical experience has shown this drug to have a low incidence of disulfiram-like alcohol reactions.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Hypoglycemia</p>
<p><b>Uncommon</b> (less than 1%): Thirst</p>
<p><b>Frequency not reported</b>: Disulfiram like reactions, hepatic porphyria, hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), elevation of LDH<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leucopenia, agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, pancytopenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Syncope</p>
<p><b>Uncommon</b> (less than 1%): Arrhythmia, flushing, hypertension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Impaired hepatic function, hepatitis, jaundice, mild to moderate ALT, LDH, alkaline phosphatase elevations</p>
<p><b>Postmarketing reports</b>: Cholestatic and hepatocellular forms of liver injury accompanied by jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects frequently disappear with continued therapy.  Photosensitivity has been reported with other sulfonylureas.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Sweating, pruritus</p>
<p><b>Uncommon</b> (less than 1%): Rash, urticaria</p>
<p><b>Frequency not reported</b>: Rash, erythema, morbilliform or maculopapular eruptions, urticaria, pruritus, eczema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, gastralgia, vomiting, flatulence, dyspepsia</p>
<p><b>Uncommon</b> (less than 1%): Anorexia, trace blood in stool</p>
<p><b>Frequency not reported</b>: Gastrointestinal irritation, gastrointestinal bleeding</p>
<p><b>Postmarketing reports</b>: Abdominal pain<sup>[Ref]</sup></p><p>Gastrointestinal side effects appear to be dose-related and may disappear on division or reduction of dosage.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria</p>
<p><b>Uncommon</b> (less than 1%): Dysuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, leg cramps, myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, nervousness, tremors, paresthesia, hypesthesia</p>
<p><b>Uncommon</b> (less than 1%): Migraine</p>
<p><b>Frequency not reported</b>: Drowsiness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p>
<p><b>Uncommon</b> (less than 1%): Pain in the eye, conjunctivitis, retinal hemorrhage</p>
<p><b>Frequency not reported</b>: Diplopia, abnormal vision, visual impairment, decreased vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, pain</p>
<p><b>Uncommon</b> (less than 1%): Chills, edema</p>
<p><b>Frequency not reported</b>: Vertigo, malaise<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression</p>
<p><b>Frequency not reported</b>: Confusion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis</p>
<p><b>Uncommon</b> (less than 1%): Pharyngitis, dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Mild to moderate BUN and creatinine elevations</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Glucotrol (glipizide)." Pfizer US Pharmaceuticals, New York, NY. </p><p id="ref_4">4. Moder KG, Schwenk NM "A coproporphyria-like syndrome induced by glipizide." Mayo Clin Proc 66 (1991): 312-6</p><p id="ref_5">5. Lebovitz HE "Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use." Pharmacotherapy 5 (1985): 63-77</p><p id="ref_6">6. Feinglos MN, Lebovitz HE "Long-term safety and efficacy of glipizide." Am J Med 75 (1983): 60-6</p><p id="ref_7">7. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS "Glipizide: a review of its pharmacological properties and therapeutic use." Drugs 18 (1979): 329-53</p><p id="ref_8">8. Asplund K, Wiholm BE, Lundman B "Severe hypoglycaemia during treatment with glipizide." Diabet Med 8 (1991): 726-31</p><p id="ref_9">9. Prendergast BD "Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents." Clin Pharm 3 (1984): 473-85</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Glucotrol XL (glipizide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Generic Availability</li>
<li>Drug class: sulfonylureas</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Glucotrol</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Diabetes, Type 2</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glipizide: compounding powder, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The more commonly reported side effects have included dizziness, diarrhea, nervousness, tremor, hypoglycemia, and flatulence.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Disulfiram-like reactions have been reported with sulfonylureas.  Clinical experience has shown this drug to have a low incidence of disulfiram-like alcohol reactions.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Hypoglycemia</p><p><b>Uncommon</b> (less than 1%): Thirst</p><p><b>Frequency not reported</b>: Disulfiram like reactions, hepatic porphyria, hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), elevation of LDH<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leucopenia, agranulocytosis, thrombocytopenia, aplastic anemia, hemolytic anemia, pancytopenia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Syncope</p><p><b>Uncommon</b> (less than 1%): Arrhythmia, flushing, hypertension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Impaired hepatic function, hepatitis, jaundice, mild to moderate ALT, LDH, alkaline phosphatase elevations</p><p><b>Postmarketing reports</b>: Cholestatic and hepatocellular forms of liver injury accompanied by jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects frequently disappear with continued therapy.  Photosensitivity has been reported with other sulfonylureas.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Sweating, pruritus</p><p><b>Uncommon</b> (less than 1%): Rash, urticaria</p><p><b>Frequency not reported</b>: Rash, erythema, morbilliform or maculopapular eruptions, urticaria, pruritus, eczema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, constipation, gastralgia, vomiting, flatulence, dyspepsia</p><p><b>Uncommon</b> (less than 1%): Anorexia, trace blood in stool</p><p><b>Frequency not reported</b>: Gastrointestinal irritation, gastrointestinal bleeding</p><p><b>Postmarketing reports</b>: Abdominal pain<sup>[Ref]</sup></p><p>Gastrointestinal side effects appear to be dose-related and may disappear on division or reduction of dosage.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria</p><p><b>Uncommon</b> (less than 1%): Dysuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, leg cramps, myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, nervousness, tremors, paresthesia, hypesthesia</p><p><b>Uncommon</b> (less than 1%): Migraine</p><p><b>Frequency not reported</b>: Drowsiness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p><p><b>Uncommon</b> (less than 1%): Pain in the eye, conjunctivitis, retinal hemorrhage</p><p><b>Frequency not reported</b>: Diplopia, abnormal vision, visual impairment, decreased vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, pain</p><p><b>Uncommon</b> (less than 1%): Chills, edema</p><p><b>Frequency not reported</b>: Vertigo, malaise<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression</p><p><b>Frequency not reported</b>: Confusion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis</p><p><b>Uncommon</b> (less than 1%): Pharyngitis, dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Mild to moderate BUN and creatinine elevations</p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Glucotrol (glipizide)." Pfizer US Pharmaceuticals, New York, NY. </p><p id="ref_4">4. Moder KG, Schwenk NM "A coproporphyria-like syndrome induced by glipizide." Mayo Clin Proc 66 (1991): 312-6</p><p id="ref_5">5. Lebovitz HE "Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use." Pharmacotherapy 5 (1985): 63-77</p><p id="ref_6">6. Feinglos MN, Lebovitz HE "Long-term safety and efficacy of glipizide." Am J Med 75 (1983): 60-6</p><p id="ref_7">7. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS "Glipizide: a review of its pharmacological properties and therapeutic use." Drugs 18 (1979): 329-53</p><p id="ref_8">8. Asplund K, Wiholm BE, Lundman B "Severe hypoglycaemia during treatment with glipizide." Diabet Med 8 (1991): 726-31</p><p id="ref_9">9. Prendergast BD "Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents." Clin Pharm 3 (1984): 473-85</p><h2>More about Glucotrol XL (glipizide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Generic Availability</li>
<li>Drug class: sulfonylureas</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Glucotrol</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diabetes, Type 2</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>